• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雌激素相关基因多态性可能会改变异黄酮对日本男性前列腺癌风险的保护作用。

Polymorphisms in estrogen related genes may modify the protective effect of isoflavones against prostate cancer risk in Japanese men.

机构信息

Department of Public Health, Sapporo Medical University School of Medicine, Hokkaido, Japan.

出版信息

Eur J Cancer Prev. 2010 Mar;19(2):131-7. doi: 10.1097/CEJ.0b013e328333fbe2.

DOI:10.1097/CEJ.0b013e328333fbe2
PMID:19952760
Abstract

Soy isoflavones and estrogen related genes may play a major role in the etiology of prostate cancer. This study examined whether the genetic polymorphisms of estrogen receptors (ESR-alpha and ESR-beta) and cytochrome P450 19A1 (CYP19A1) modified the protective effect of isoflavones against prostate cancer. One hundred and eighty cases and 177 controls were selected from three geographic areas of Japan. The odds ratio for more than or equal to 60 versus less than 60 mg/day of the intake of isoflavones was 0.63 (95% confidence interval=0.41-0.96). The TTTA long repeat was significantly associated with an increased risk (odds ratio=1.76, 95% confidence interval=1.15-5.70). The interaction between the polymorphisms and the intake of isoflavones on prostate cancer risk was analyzed by the multifactor dimensionality reduction method. The combination of the TTTA long repeats and the minor alleles of rs10046 in CYP19A1 and rs2077647 in ESR-alpha was a high risk for prostate cancer despite greater than or equal to 60 mg isoflavones/day. The combination of the TTTA short repeat and those homozygous for the major allele of rs10046 in CYP19A1 was low risk despite less than 60 mg isoflavones/day. In conclusion, the findings of this case-control study suggest that the protective effect of isoflavones may differ between the genotypes of estrogen related genes.

摘要

大豆异黄酮和与雌激素相关的基因可能在前列腺癌的病因学中起主要作用。本研究探讨了雌激素受体(ESR-α和 ESR-β)和细胞色素 P45019A1(CYP19A1)的遗传多态性是否改变了异黄酮对前列腺癌的保护作用。从日本的三个地理区域中选择了 180 例病例和 177 例对照。每天摄入异黄酮量大于或等于 60 毫克与小于 60 毫克的比值比为 0.63(95%置信区间为 0.41-0.96)。TTTA 长重复与风险增加显著相关(比值比=1.76,95%置信区间为 1.15-5.70)。采用多因素降维法分析了多态性与异黄酮摄入对前列腺癌风险的相互作用。尽管每天摄入异黄酮量大于或等于 60 毫克,但 CYP19A1 中的 rs10046 多态性的 TTTA 长重复和 minor 等位基因以及 ESR-α 中的 rs2077647 的组合仍是前列腺癌的高危因素。尽管每天摄入异黄酮量小于 60 毫克,但 CYP19A1 中的 rs10046 多态性的 TTTA 短重复和 major 等位基因的纯合子是低危因素。总之,这项病例对照研究的结果表明,异黄酮的保护作用可能因与雌激素相关的基因的基因型而异。

相似文献

1
Polymorphisms in estrogen related genes may modify the protective effect of isoflavones against prostate cancer risk in Japanese men.雌激素相关基因多态性可能会改变异黄酮对日本男性前列腺癌风险的保护作用。
Eur J Cancer Prev. 2010 Mar;19(2):131-7. doi: 10.1097/CEJ.0b013e328333fbe2.
2
Isoflavone, polymorphisms in estrogen receptor genes and breast cancer risk in case-control studies in Japanese, Japanese Brazilians and non-Japanese Brazilians.异黄酮、雌激素受体基因多态性与日本、日裔巴西人和非日裔巴西人病例对照研究中的乳腺癌风险
Cancer Sci. 2009 May;100(5):927-33. doi: 10.1111/j.1349-7006.2009.01118.x. Epub 2009 Feb 26.
3
Soy isoflavones, CYP1A1, CYP1B1, and COMT polymorphisms, and breast cancer: a case-control study in southwestern China.大豆异黄酮、CYP1A1、CYP1B1 和 COMT 多态性与乳腺癌:中国西南部的病例对照研究。
DNA Cell Biol. 2011 Aug;30(8):585-95. doi: 10.1089/dna.2010.1195. Epub 2011 Mar 27.
4
Association between estrogen and androgen receptor genes and prostate cancer risk.雌激素和雄激素受体基因与前列腺癌风险之间的关联。
Eur J Endocrinol. 2009 Jan;160(1):101-6. doi: 10.1530/EJE-08-0321. Epub 2008 Oct 24.
5
Association of variants in estrogen-related pathway genes with prostate cancer risk.雌激素相关通路基因变异与前列腺癌风险的关联。
Prostate. 2013 Jan;73(1):1-10. doi: 10.1002/pros.22534. Epub 2012 May 1.
6
Estrogen receptors alpha (rs2234693 and rs9340799), and beta (rs4986938 and rs1256049) genes polymorphism in prostate cancer: evidence for association with risk and histopathological tumor characteristics in Iranian men.雌激素受体 α(rs2234693 和 rs9340799)和 β(rs4986938 和 rs1256049)基因多态性与前列腺癌的关系:伊朗男性风险和组织病理学肿瘤特征的关联证据。
Mol Carcinog. 2012 Oct;51 Suppl 1:E104-17. doi: 10.1002/mc.21870. Epub 2012 Jan 6.
7
Association of testicular germ cell tumor with polymorphisms in estrogen receptor and steroid metabolism genes.睾丸生殖细胞肿瘤与雌激素受体和类固醇代谢基因多态性的关联。
Endocr Relat Cancer. 2010 Jan 29;17(1):17-25. doi: 10.1677/ERC-09-0176. Print 2010 Mar.
8
Genetic polymorphisms of estrogen receptors alpha and beta and the risk of developing prostate cancer.雌激素受体 α 和 β 的遗传多态性与前列腺癌发病风险的关系。
PLoS One. 2009 Aug 5;4(8):e6523. doi: 10.1371/journal.pone.0006523.
9
Effect of soy isoflavones on endometriosis: interaction with estrogen receptor 2 gene polymorphism.大豆异黄酮对子宫内膜异位症的影响:与雌激素受体2基因多态性的相互作用。
Epidemiology. 2007 May;18(3):402-8. doi: 10.1097/01.ede.0000257571.01358.f9.
10
Polymorphisms in genes of the steroid receptor superfamily modify postmenopausal breast cancer risk associated with menopausal hormone therapy.甾体激素受体超家族基因多态性改变与绝经后激素治疗相关的绝经后乳腺癌风险。
Int J Cancer. 2010 Jun 15;126(12):2935-46. doi: 10.1002/ijc.24892.

引用本文的文献

1
ESR2 polymorphisms on prostate cancer risk: A systematic review and meta-analysis.ESR2 多态性与前列腺癌风险:系统评价和荟萃分析。
Medicine (Baltimore). 2023 Jun 9;102(23):e33937. doi: 10.1097/MD.0000000000033937.
2
Synonymous Variants: Necessary Nuance in Our Understanding of Cancer Drivers and Treatment Outcomes.同义变体:在理解癌症驱动因素和治疗结果时需要注意的细微差别。
J Natl Cancer Inst. 2022 Aug 8;114(8):1072-1094. doi: 10.1093/jnci/djac090.
3
The CYP19A1 (TTTA)n Repeat Polymorphism May Affect the Prostate Cancer Risk: Evidence from a Meta-Analysis.
CYP19A1(TTTA)n 重复多态性可能影响前列腺癌风险:来自荟萃分析的证据。
Am J Mens Health. 2021 May-Jun;15(3):15579883211017033. doi: 10.1177/15579883211017033.
4
Dietary Assessment Methods to Estimate (Poly)phenol Intake in Epidemiological Studies: A Systematic Review.膳食评估方法评估流行病学研究中(多)酚类物质的摄入量:系统综述。
Adv Nutr. 2021 Oct 1;12(5):1781-1801. doi: 10.1093/advances/nmab017.
5
PvuII (rs2234693 T>C) polymorphism and cancer susceptibility: Evidence from 80 studies.PvuII(rs2234693 T>C)多态性与癌症易感性:来自80项研究的证据。
J Cancer. 2018 Jul 30;9(16):2963-2972. doi: 10.7150/jca.25638. eCollection 2018.
6
Comprehensive assessment of the association between estrogen receptor of alpha polymorphisms and the risk of prostate cancer: evidence from a meta-analysis.α多态性雌激素受体与前列腺癌风险关联的综合评估:一项荟萃分析的证据
Oncotarget. 2017 Sep 21;8(60):102310-102320. doi: 10.18632/oncotarget.21117. eCollection 2017 Nov 24.
7
In silico characterization of functional SNP within the oestrogen receptor gene.雌激素受体基因内功能性单核苷酸多态性的计算机模拟特征分析
J Genet. 2016 Dec;95(4):865-874. doi: 10.1007/s12041-016-0707-1.
8
Molecular basis for prostate cancer racial disparities.前列腺癌种族差异的分子基础。
Front Biosci (Landmark Ed). 2017 Jan 1;22(3):428-450. doi: 10.2741/4493.
9
Isoflavones and Prostate Cancer: A Review of Some Critical Issues.异黄酮与前列腺癌:一些关键问题的综述
Chin Med J (Engl). 2016 Feb 5;129(3):341-7. doi: 10.4103/0366-6999.174488.
10
Current evidence on the relationship between rs1256049 polymorphism in estrogen receptor-β gene and cancer risk.雌激素受体-β基因中rs1256049多态性与癌症风险之间关系的当前证据。
Int J Clin Exp Med. 2014 Dec 15;7(12):5031-40. eCollection 2014.